Skip to Content


In the US, Nolvadex (tamoxifen systemic) is a member of the following drug classes: hormones/antineoplastics, selective estrogen receptor modulators and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Male, Breast Cancer - Metastatic, Breast Cancer - Palliative, McCune-Albright Syndrome and Precocious Puberty.

US matches:

Ingredient matches for Nolvadex


Tamoxifen is reported as an ingredient of Nolvadex in the following countries:

  • Bulgaria
  • Egypt
  • India
  • Lebanon
  • Oman

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Nolvadex in the following countries:

  • Australia
  • Austria
  • Bangladesh
  • Belgium
  • Brazil
  • Croatia (Hrvatska)
  • Ecuador
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Japan
  • Malta
  • Mexico
  • Norway
  • Portugal
  • Serbia
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Turkey
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.